TY - GEN AU - Chen,Zhao AU - Cheng,Katherine AU - Walton,Zandra AU - Wang,Yuchuan AU - Ebi,Hiromichi AU - Shimamura,Takeshi AU - Liu,Yan AU - Tupper,Tanya AU - Ouyang,Jing AU - Li,Jie AU - Gao,Peng AU - Woo,Michele S AU - Xu,Chunxiao AU - Yanagita,Masahiko AU - Altabef,Abigail AU - Wang,Shumei AU - Lee,Charles AU - Nakada,Yuji AU - Peña,Christopher G AU - Sun,Yanping AU - Franchetti,Yoko AU - Yao,Catherine AU - Saur,Amy AU - Cameron,Michael D AU - Nishino,Mizuki AU - Hayes,D Neil AU - Wilkerson,Matthew D AU - Roberts,Patrick J AU - Lee,Carrie B AU - Bardeesy,Nabeel AU - Butaney,Mohit AU - Chirieac,Lucian R AU - Costa,Daniel B AU - Jackman,David AU - Sharpless,Norman E AU - Castrillon,Diego H AU - Demetri,George D AU - Jänne,Pasi A AU - Pandolfi,Pier Paolo AU - Cantley,Lewis C AU - Kung,Andrew L AU - Engelman,Jeffrey A AU - Wong,Kwok-Kin TI - A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response SN - 1476-4687 PY - 2012///0508 KW - AMP-Activated Protein Kinases KW - Animals KW - Antineoplastic Combined Chemotherapy Protocols KW - Benzimidazoles KW - pharmacology KW - Biomarkers, Tumor KW - genetics KW - Clinical Trials, Phase II as Topic KW - Disease Models, Animal KW - Docetaxel KW - Drug Evaluation, Preclinical KW - Fluorodeoxyglucose F18 KW - Genes, p53 KW - Humans KW - Lung Neoplasms KW - drug therapy KW - MAP Kinase Signaling System KW - drug effects KW - Mice KW - Mitogen-Activated Protein Kinase Kinases KW - antagonists & inhibitors KW - Mutation KW - Pharmacogenetics KW - methods KW - Positron-Emission Tomography KW - Protein Serine-Threonine Kinases KW - deficiency KW - Proto-Oncogene Proteins KW - Proto-Oncogene Proteins p21(ras) KW - Randomized Controlled Trials as Topic KW - Reproducibility of Results KW - Taxoids KW - therapeutic use KW - Tomography, X-Ray Computed KW - Treatment Outcome KW - ras Proteins N1 - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't UR - https://doi.org/10.1038/nature10937 ER -